.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Teva
AstraZeneca
Accenture
Mallinckrodt
Johnson and Johnson
Harvard Business School
Citi
Novartis
US Department of Justice

Generated: February 17, 2018

DrugPatentWatch Database Preview

Calcium Drug-Class List

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
AlvogenADALAT CCnifedipineTABLET, EXTENDED RELEASE;ORAL020198-001Apr 21, 1993AB1RXYesNo➤ Sign Up➤ Sign Up➤ Sign Up
AlvogenADALAT CCnifedipineTABLET, EXTENDED RELEASE;ORAL020198-002Apr 21, 1993AB1RXYesYes➤ Sign Up➤ Sign Up➤ Sign Up
AlvogenADALAT CCnifedipineTABLET, EXTENDED RELEASE;ORAL020198-003Apr 21, 1993AB1RXYesYes➤ Sign Up➤ Sign Up➤ Sign Up
Watson Labs TevaAFEDITAB CRnifedipineTABLET, EXTENDED RELEASE;ORAL075128-001Mar 10, 2000AB1RXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Watson LabsAFEDITAB CRnifedipineTABLET, EXTENDED RELEASE;ORAL075659-001Oct 26, 2001AB1RXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Aurobindo Pharma LtdAMLODIPINE AND OLMESARTAN MEDOXOMILamlodipine besylate; olmesartan medoxomilTABLET;ORAL206906-004May 15, 2017ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Alembic Pharms LtdAMLODIPINE AND OLMESARTAN MEDOXOMILamlodipine besylate; olmesartan medoxomilTABLET;ORAL207073-001Jul 17, 2017ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Jubilant GenericsAMLODIPINE AND OLMESARTAN MEDOXOMILamlodipine besylate; olmesartan medoxomilTABLET;ORAL207450-002May 15, 2017ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Glenmark Pharms LtdAMLODIPINE AND OLMESARTAN MEDOXOMILamlodipine besylate; olmesartan medoxomilTABLET;ORAL207807-002Jul 5, 2017ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Teva Pharms UsaAMLODIPINE AND OLMESARTAN MEDOXOMILamlodipine besylate; olmesartan medoxomilTABLET;ORAL091154-003Oct 26, 2016ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
AstraZeneca
Fuji
QuintilesIMS
Federal Trade Commission
Dow
Teva
Boehringer Ingelheim
Fish and Richardson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot